125 related articles for article (PubMed ID: 20470697)
1. [Assessment of the PCA3 test for prostate cancer diagnosis: a systematic review and meta-analysis].
Ruiz-Aragón J; Márquez-Peláez S
Actas Urol Esp; 2010 Apr; 34(4):346-55. PubMed ID: 20470697
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer antigen 3 test for prostate biopsy decision: a systematic review and meta analysis.
Luo Y; Gou X; Huang P; Mou C
Chin Med J (Engl); 2014; 127(9):1768-74. PubMed ID: 24791889
[TBL] [Abstract][Full Text] [Related]
3. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis.
Cui Y; Cao W; Li Q; Shen H; Liu C; Deng J; Xu J; Shao Q
Sci Rep; 2016 May; 6():25776. PubMed ID: 27161545
[TBL] [Abstract][Full Text] [Related]
5. The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis.
Luo Y; Gou X; Huang P; Mou C
Asian J Androl; 2014; 16(3):487-92. PubMed ID: 24713827
[TBL] [Abstract][Full Text] [Related]
6. Molecular PCA3 diagnostics on prostatic fluid.
van Gils MP; Cornel EB; Hessels D; Peelen WP; Witjes JA; Mulders PF; Rittenhouse HG; Schalken JA
Prostate; 2007 Jun; 67(8):881-7. PubMed ID: 17440939
[TBL] [Abstract][Full Text] [Related]
7. Comparison of diagnostic efficacy by two urine PCA3 scores in prostate cancer patients undergoing repeat biopsies.
Jiang Z; Zhao Y; Tian Y
Minerva Urol Nefrol; 2019 Aug; 71(4):373-380. PubMed ID: 30203935
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of prostate cancer antigen 3 (PCA3) prior to first prostate biopsy: A systematic review and meta-analysis.
Rodríguez SVM; García-Perdomo HA
Can Urol Assoc J; 2020 May; 14(5):E214-E219. PubMed ID: 31793864
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer.
Bradley LA; Palomaki GE; Gutman S; Samson D; Aronson N
J Urol; 2013 Aug; 190(2):389-98. PubMed ID: 23545099
[TBL] [Abstract][Full Text] [Related]
10. DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer.
Tinzl M; Marberger M; Horvath S; Chypre C
Eur Urol; 2004 Aug; 46(2):182-6; discussion 187. PubMed ID: 15245811
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis.
Xue WJ; Ying XL; Jiang JH; Xu YH
J Cancer Res Ther; 2014 Nov; 10 Suppl():C218-21. PubMed ID: 25450286
[TBL] [Abstract][Full Text] [Related]
12. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
Klecka J; Holubec L; Pesta M; Topolcan O; Hora M; Eret V; Finek J; Chottova-Dvorakova M; Babjuk M; Novak K; Stolz J
Anticancer Res; 2010 Feb; 30(2):665-70. PubMed ID: 20332487
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of the Prostate Cancer Antigen 3 Test in Prostate Cancer: Systematic Review and Meta-analysis.
Lee D; Shim SR; Ahn ST; Oh MM; Moon DG; Park HS; Cheon J; Kim JW
Clin Genitourin Cancer; 2020 Oct; 18(5):402-408.e5. PubMed ID: 32280028
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis accuracy of PCA3 level in patients with prostate cancer: a systematic review with meta-analysis.
Qin Z; Yao J; Xu L; Xu Z; Ge Y; Zhou L; Zhao F; Jia R
Int Braz J Urol; 2020; 46(5):691-704. PubMed ID: 31961625
[TBL] [Abstract][Full Text] [Related]
15. Progensa™ PCA3 test for prostate cancer.
Durand X; Moutereau S; Xylinas E; de la Taille A
Expert Rev Mol Diagn; 2011 Mar; 11(2):137-44. PubMed ID: 21405964
[TBL] [Abstract][Full Text] [Related]
16. The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.
van Gils MP; Hessels D; van Hooij O; Jannink SA; Peelen WP; Hanssen SL; Witjes JA; Cornel EB; Karthaus HF; Smits GA; Dijkman GA; Mulders PF; Schalken JA
Clin Cancer Res; 2007 Feb; 13(3):939-43. PubMed ID: 17289888
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of urine prostate cancer antigen 3 test using a cutoff value of 35 μg/L in patients with prostate cancer.
Hu B; Yang H; Yang H
Tumour Biol; 2014 Sep; 35(9):8573-80. PubMed ID: 24863945
[TBL] [Abstract][Full Text] [Related]
18. The role of urine prostate cancer antigen 3 mRNA levels in the diagnosis of prostate cancer among Hong Kong Chinese patients.
Ng CF; Yeung R; Chiu PK; Lam NY; Chow J; Chan B
Hong Kong Med J; 2012 Dec; 18(6):459-65. PubMed ID: 23223645
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
[TBL] [Abstract][Full Text] [Related]
20. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]